Philips Medical Systems will launch the latest version of its JetStream Workspace at the Society of Nuclear Medicine meeting in San Diego next week.The enhanced product, Version 3.0, features new workflow and image-display capabilities. Incremental improvements have been made in cardiac, bone, renal, salivary, and brain imaging.
Philips Medical Systems will launch the latest version of its JetStream Workspace at the Society of Nuclear Medicine meeting in San Diego next week.
The enhanced product, Version 3.0, features new workflow and image-display capabilities. Incremental improvements have been made in cardiac, bone, renal, salivary, and brain imaging.
"There are a lot of little things that add up to a big improvement," said Deepak Malhotra, senior director of marketing and business development for Philips nuclear medicine.
Malhotra noted that this latest version of JetStream has more than 200 individual enhancements. Each is based on customer feedback obtained since the product was released in April 2005 as Version 2.0.
The newest version can be obtained in IDL programming language, which allows customers to develop and customize applications. The product, which is compatible with all of Philips' gamma cameras, will be available for delivery in fall.
Version 3.0, like its predecessor, will be available in configurations designed for general nuclear medicine, cardiac, and study review. The upgraded product will be available to all users, although general nuclear medicine customers will benefit the most, Malhotra said.
The software is essentially complete right now, Malhotra said, but there may be "a few tweaks" before it begins shipping commercially.
"We will go through extensive clinical validation at customer sites," he said. "Based on their feedback, we might make some last minute adjustments."
Philips is counting on getting advice from at least five clinical sites.
What Emerging CT Research Reveals About Obesity and Post-Op Survival for Non-Small Cell Lung Cancer
January 29th 2025For those without low skeletal muscle mass on CT and myosteatosis, obese patients have a 23 percent lower risk of death than non-obese patients after undergoing curative resection for non-small cell lung cancer, according to newly published research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.